コピー
I'm a partner in https://congresodeteologia.info/rosuvastatin-teva-10-mg-biverkningar-cazf rosuvastatin ranbaxy The drugmaker said on Thursday that updated data from aclinical study showed its experimental product, sapacitabine,has activity against a majority of ovarian cancer samples takenfrom patients, including resistant tumors. The drug is currentlybeing tested in late-stage studies as a as front-line treatmentfor acute myeloid leukemia in the elderly.
TOPに戻る
-
iboard BASIC
-